Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -29.90 is 100% above its 5-year average of -180507.78, near the high end of its 5-year range (-503023.26–-4.75).
82.94% above its 12-month average of -175.25.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.10.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-29.90
EARNINGS PER SHARE (EPS) AVG TTM
-175.25
EARNINGS PER SHARE (EPS) AVG 3Y
-40254.86
EARNINGS PER SHARE (EPS) AVG 5Y
-180507.78
EARNINGS PER SHARE (EPS) AVG 10Y
-2019474.59
EARNINGS PER SHARE (EPS) AVG 15Y
-109323.85
EARNINGS PER SHARE (EPS) AVG 20Y
-31767.30
CURRENT VS TTM AVG
+82.94%
CURRENT VS 3Y AVG
+99.93%
CURRENT VS 5Y AVG
+99.98%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+99.97%
CURRENT VS 20Y AVG
+99.91%
Vyome Holdings, Inc.
Market Cap
$14.11M
Earnings Per Share (EPS)
-29.90
TTM Avg
-175.25
3Y Avg
-40254.86
5Y Avg
-180507.78
Market Cap
$14.11M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.17
3Y Avg
-1.46
5Y Avg
-1.36
Market Cap
$13.81M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.99M
Earnings Per Share (EPS)
-5.41
TTM Avg
-10.52
3Y Avg
-27.78
5Y Avg
-33.88
Market Cap
$13.48M
Earnings Per Share (EPS)
-1.39
TTM Avg
-1.16
3Y Avg
-1.40
5Y Avg
-1.09
Market Cap
$15.03M
Earnings Per Share (EPS)
-2.46
TTM Avg
-7.80
3Y Avg
-9.74
5Y Avg
-7.20
Market Cap
$13.33M
Earnings Per Share (EPS)
-1.87
TTM Avg
-10.75
3Y Avg
-23.11
5Y Avg
-21.98
Market Cap
$13.37M
Earnings Per Share (EPS)
-2.11
TTM Avg
-3.38
3Y Avg
-4.90
5Y Avg
-6.31
Market Cap
$15.24M
Earnings Per Share (EPS)
-0.77
TTM Avg
-1.25
3Y Avg
-1.82
5Y Avg
-1.86
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vyome Holdings, Inc. (HIND) | $14.11M | -29.90 | -175.25 | -40254.86 | -180507.78 |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.11M | N/A | -1.17 | -1.46 | -1.36 |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.81M | N/A | N/A | N/A | N/A |
| Sintx Technologies, Inc. (SINT)vs › | $13.99M | -5.41 | -10.52 | -27.78 | -33.88 |
| Optimi Health Corp. (OPTH)vs › | $13.48M | -1.39 | -1.16 | -1.40 | -1.09 |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.03M | -2.46 | -7.80 | -9.74 | -7.20 |
| IN8bio, Inc. (INAB)vs › | $13.33M | -1.87 | -10.75 | -23.11 | -21.98 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.37M | -2.11 | -3.38 | -4.90 | -6.31 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.24M | -0.77 | -1.25 | -1.82 | -1.86 |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.96M | -13.07 | -13.67 | -19.10 | -23.67 |
Trailing EPS (TTM)
$-29.90
Forward EPS (Est.)
$-0.65
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -4.75 |
| 2024-12-31 | -345.74 |
| 2023-12-31 | -2771.94 |
| 2022-12-31 | -157897.00 |
| 2021-12-31 | -419004.00 |
| 2020-12-31 | -503023.26 |
| 2017-12-31 | -4524000.00 |
| 2016-12-31 | -10548750.00 |
| 2013-12-31 | 0.00 |
| 2012-12-31 | -1720.86 |
| 2011-12-31 | -2495.74 |
| 2010-12-31 | -5975.16 |
| 2009-12-31 | -18614.52 |
| 2008-12-31 | -6523.84 |
| 2007-12-31 | -33892.88 |
| 2006-12-31 | -99144.62 |
| 2005-12-31 | -83587.86 |
| 2004-12-31 | -70656.18 |
| 2003-12-31 | -34672.40 |
